David Close

David Close is an accomplished Executive Director of Early Clinical Research and Development at AstraZeneca, where they are responsible for disease strategy and early phase drug development in immunology. Previously, they served as Clinical Director at MedImmune Ltd, leading strategic clinical development in inflammation and autoimmunity. David has also held roles as Senior Director of Clinical Research and Medical Director at AstraZeneca, focusing on respiratory and inflammatory conditions. Their extensive background in clinical development includes over a decade at Roche Pharmaceuticals, where they led global teams in various phases of drug development. David earned a PhD in Rheumatology and Clinical Immunology from Keele University and holds a Bachelor's degree in Medical Biochemistry from the University of Leeds.